Felicity Ryan
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- SARS-CoV-2 detection and testing 1
- Otolaryngology and Infectious Diseases 1
- Antifungal resistance and susceptibility 1
-
- Nosocomial Infections in ICU 1
- Co-authors
- Hannah Lowe (1 shared paper)Stephen K Glass (1 shared paper)Samuel E Moses (1 shared paper)C. Arenas Linares (1 shared paper)Campbell W. Gourlay (1 shared paper)
- Journals
- Nature Microbiology (1 paper)Clinical Medicine (1 paper)International Journal of Antimicrobial Agents (1 paper)Scientific Reports (1 paper)Cell (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Felicity Ryan
5 papers receiving 1.3k citations
Felicity Ryan's Hit Papers
Peers
Comparison fields: 5 of 72
- Infectious Diseases 1.2k
- Modeling and Simulation 95
- Neurology 21
- Genetics 39
- Animal Science and Zoology 11
Countries citing papers authored by Felicity Ryan
This map shows the geographic impact of Felicity Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felicity Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felicity Ryan more than expected).
Fields of papers citing papers by Felicity Ryan
This network shows the impact of papers produced by Felicity Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felicity Ryan. The network helps show where Felicity Ryan may publish in the future.
Co-authors
The 5 scholars most cited alongside Felicity Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 756 | |
| 2 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 571 |
| 3 | 2022 | 45 | |
| 4 | 2020 | 4 | |
| 5 | 2021 | 2 | |
| 6 | 2025 | 0 | |
| 7 | 2026 | 0 |
About Felicity Ryan
Felicity Ryan is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Molecular Medicine, Molecular Biology and Nuclear Energy and Engineering, having authored 7 papers that have together received 1.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), SARS-CoV-2 detection and testing (1 paper), Otolaryngology and Infectious Diseases (1 paper), Antifungal resistance and susceptibility (1 paper), Bacterial biofilms and quorum sensing (1 paper), Nosocomial Infections in ICU (1 paper) and Antibiotic Resistance in Bacteria (1 paper). The work is most often cited by research in Infectious Diseases (1.2k citations), Modeling and Simulation (95 citations), Neurology (21 citations), Genetics (39 citations) and Animal Science and Zoology (11 citations). Felicity Ryan has collaborated with scholars based in United Kingdom. Frequent co-authors include Hannah Lowe, Stephen K Glass, Samuel E Moses, C. Arenas Linares and Campbell W. Gourlay. Their work appears in journals such as Nature Microbiology, Clinical Medicine, International Journal of Antimicrobial Agents, Scientific Reports and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.